Home Shop Fas (human):Fc (human), (recombinant)

Fas (human):Fc (human), (recombinant)

ALX-522-002

14 citations

Datasheet
Manual
SDS
CofA

Already have an account?

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Fas (human):Fc (human), (recombinant) SDS-PAGE

Fas (human):Fc (human), (recombinant) image — **Figure:** Inhibition of FasL, Soluble (human) (rec.) (Prod. No. ALX-522-001)-mediated lysis. Fas (human):Fc (human) (rec.) (Prod. No. ALX-522-002) exerts its inhibitory activity in a concentration range of 0.5-5µg/ml in the presence of the enhancer (1µg/ml).Method: Mouse A20 B lymphoma cells (50’000 cells in 100µl DMEM medium containing 5% fetal calf serum) were incubated with 0.2µg/ml FasL

Product Details

Alternative Name	CD95, APO-1, TNFRSF 6
Application Notes	ELISA: binds to FasL at 10-100 ng/ml.
Concentration	1mg/ml after reconstitution.
Endotoxin Content	<0.1EU/µg purified protein (LAL test; Associates of Cape Cod).
Formulation	Lyophilized. Contains PBS.
MW	~56 kDa
Purity	≥95% (SDS-PAGE)
Purity Detail	Purified by multi-step chromatography.
Reconstitution	Reconstitute with 50µl sterile water. Further dilutions can be made with medium containing 5% fetal calf serum or a carrier protein.
Source	Produced in HEK 293 cells. The extracellular domain of human Fas (CD95; APO-1) (aa 7-154) is fused to the Fc portion of human IgG1.
Specificity	Binds human, mouse and rat FasL (APO-1L; CD95L; CD178).
Technical Info / Product Notes	Historical data has shown that Fas inhibits the activity of human and mouse soluble Fas (sFasL) and thereby sFasL-mediated lysis of Fas sensitive cells in a concentration range of 20-100µg/ml. When used with cross-linking enhancer (see Prod. No. ALX-203-001), the inhibitory activity of rhFas:Fc is increased approximately 20- to 50-fold. Concentrations of rhFas:Fc required to inhibit may vary depending on the cell viability and on the concentrations of sFasL used to kill the cells.
UniProt ID	P25445

Handling & Storage

Use/Stability	Stable for at least 6 months after receipt when stored at -20°C.
Handling	Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C.
Long Term Storage	-20°C
Shipping	Blue Ice

Regulatory Status	RUO – Research Use Only

Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells: M.A. Fuse, et al.; Mol. Cancer Ther. 16, 2387 (2017), Abstract
Pigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): T.C. Ho, et al.; J. Biol. Chem. 286, 35943 (2011), Abstract — Full Text
Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8: M.A. Laussmann, et al.; Cell Death Differ. 18, 1584 (2011), Abstract
Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection: W. Hou, et al.; J. Exp. Med. 206, 313 (2009), Abstract — Full Text
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex: N. Holler, et al.; Mol. Cell. Biol. 23, 1428 (2003), Abstract — Full Text
High expression of Fas ligand by synovial fluid-derived gamma delta T cells in Lyme arthritis: K. Roessner, et al.; J. Immunol. 170, 2702 (2003), Abstract — Full Text
Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death: F. Petit et al; J. Biol. Chem. 277, 1477 (2002), Abstract — Full Text
Estrogen Receptor–Mediated, Nitric Oxide–Dependent Modulation of the Immunologic Barrier Function of the Endothelium: C. Amant, et al.; Circulation 104, 2576 (2001), Application(s): Cytotoxicity assay with HUVEC & Jurkat cells, Abstract
Mechanisms underlying neuronal death induced by chromogranin A-activated microglia: J. Ciesielski-Treska, et al.; J. Biol. Chem. 276, 13113 (2001), Abstract — Full Text
T cell costimulation by the TNF ligand BAFF: B. Huard et al.; J. Immunol. 167, 6225 (2001), Abstract

Related Products

Enhancer for Receptors

ALX-203-001

1 citation

Control:Fc fusion protein (human), (recombinant)

ALX-203-004

Negative control for Fc chimeric proteins

11 citations

Alternative Name	Thy-1 (RLE mutant)
Purity	≥90% (SDS-PAGE)
Source	Produced in HEK 293 cells. The extracellular domain of mutated hThy-1, hThy-1 (RLE) (aa 20-130), is fused to the Fc portion of human IgG1. The integrin binding sequence RLD of hThy-1 has been changed to RLE abolishing the binding of integrins.

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Datasheet

Certificate of Analysis

Please enter the lot number as featured on the product label

Lot No. :

SDS

Enzo Life Science provides GHS Compliant SDS

If your language is not available please fill out the SDS request form

Your Cart

Your Cart

Fas (human):Fc (human), (recombinant)

ALX-522-002

Product Details

Handling & Storage

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Certificate of Analysis

SDS

Change Country

Tell us about You

Tell us about your paper

Tell us about You

Tell us about your project